Drugs / Licensed measles vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01557699 Comparator | Mar 2012 → Feb 2013 | measles | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licensed measles vaccine | “Licensed measles vaccine will be administered subcutaneously as single dose of 0.5 ml.” NCT01557699 ↗ |
| Modality | Vaccine | “This is a licensed formulation containing the live attenuated Edmonston Zagreb virus.” NCT01557699 ↗ |
| Route | Subcutaneous | “This is a licensed formulation containing the live attenuated Edmonston Zagreb virus. A single dose of 0.5 ml will be given subcutaneously.” NCT01557699 ↗ |